Literature DB >> 26896740

The fatality and morbidity components of the value of statistical life.

Elissa Philip Gentry1, W Kip Viscusi2.   

Abstract

The fatality risk-money tradeoff that is the value of a statistical life (VSL) may vary with the nature of the fatality event. While all fatalities involve loss of future life expectancy, the morbidity effects and their duration may differ. This article analyzes fatality risks accompanied by morbidity effects of different duration to disentangle the mortality and morbidity components of VSL using data from the Census of Fatal Occupational Injuries (CFOI). The VSL is comprised of the sum of the value of the fatality risk and the value of the morbidity risk. Labor market valuations of morbidity risks are positive, even for fatalities that are caused by traumatic injuries. The value of the fatality risk is the dominant component of VSL, rather than the value of the morbidity risk.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Census of Fatal Occupational Injuries; Fatality; Morbidity; VSL; Value of a statistical life

Mesh:

Year:  2016        PMID: 26896740     DOI: 10.1016/j.jhealeco.2016.01.011

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  5 in total

1.  Pricing the global health risks of the COVID-19 pandemic.

Authors:  W Kip Viscusi
Journal:  J Risk Uncertain       Date:  2020-11-02

2.  Economic lessons for COVID-19 pandemic policies.

Authors:  W Kip Viscusi
Journal:  South Econ J       Date:  2021-03-04

3.  Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks.

Authors:  Minah Park; Mark Jit; Joseph T Wu
Journal:  BMC Med       Date:  2018-09-05       Impact factor: 8.775

4.  "Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom.

Authors:  David K Miles; Michael Stedman; Adrian H Heald
Journal:  Int J Clin Pract       Date:  2020-09-21       Impact factor: 3.149

5.  Do the Benefits of COVID-19 Policies Exceed the Costs? Exploring Uncertainties in the Age-VSL Relationship.

Authors:  Lisa A Robinson; Ryan Sullivan; Jason F Shogren
Journal:  Risk Anal       Date:  2020-07-16       Impact factor: 4.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.